News

GlobalData on MSN2mon
Supernus wins FDA approval for Parkinson’s pump on fourth try
The wearable pump is designed to provide a continuous subcutaneous infusion of Supernus’ apomorphine (Apokyn). The drug is ...
Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease
Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today announced the closing of ...
pharmaphorum1y
NICE backs pump-based Parkinson’s drug from AbbVie
AbbVie asked for Produodopa to be considered for use in patients who cannot have apomorphine – an ... from other subcutaneous infusion therapies, notably Mitsubishi Tanabe Pharma’s ND-0612 ...